CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 1, Pages 45-52
Publisher
Wiley
Online
2012-03-10
DOI
10.1002/pbc.24117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
- (2015) Jiri Sana et al. Analytical Cellular Pathology
- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: A report from the Children's Oncology Group
- (2011) Joseph G. Pressey et al. PEDIATRIC BLOOD & CANCER
- CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
- (2011) Dagmar Walter et al. PLoS One
- Cancer Stem Cells and Pediatric Solid Tumors
- (2011) Gregory K. Friedman et al. Cancers
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- 2D-Difference Gel Electrophoretic Proteomic Analysis of a Cell Culture Model of Alveolar Rhabdomyosarcoma
- (2010) Joseph G. Pressey et al. JOURNAL OF PROTEOME RESEARCH
- Muscling in: Uncovering the origins of rhabdomyosarcoma
- (2010) Simone Hettmer et al. NATURE MEDICINE
- Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma
- (2010) A Zibat et al. ONCOGENE
- Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis
- (2009) Kuan Chih Lang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
- (2009) M Hirotsu et al. BRITISH JOURNAL OF CANCER
- Radiation responses of cancer stem cells
- (2009) Erina Vlashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment
- (2009) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
- (2009) Gregory K. Friedman et al. JOURNAL OF NEURO-ONCOLOGY
- Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies
- (2009) Gregory K Friedman et al. MOLECULAR THERAPY
- In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study
- (2009) Elisa Negroni et al. MOLECULAR THERAPY
- Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
- (2009) Yonatan Y. Mahller et al. PLoS One
- Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?
- (2008) Elizabeth Charytonowicz et al. CANCER LETTERS
- Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration
- (2008) Giuseppe Straface et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population
- (2008) Naomi Pode-Shakked et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Presence of pluripotent CD133+ cells correlates with malignancy of gliomas
- (2008) Niklas Thon et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
- (2008) Virginia Tirino et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started